Combined tDCS and Pneumatic Compression for Recovery After a 10K Run
NCT ID: NCT07333404
Last Updated: 2026-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
35 participants
INTERVENTIONAL
2026-01-05
2026-06-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Men aged 40-55 who are trained long-distance runners can participate, provided they do not have medical conditions that prevent safe exercise or use of the recovery methods. Participants will run 10K and then receive one of the following interventions in a randomized order: tDCS, PC, tDCS + PC, or no intervention (control). Each participant will experience all conditions, with a one-week break between sessions. Measurements will be taken before the run, immediately after, and after the intervention, including heart rate variability, cognitive tests (Stroop Test), vertical jump, and maximal voluntary muscle contraction, during which muscle activity will be recorded using electromyography (EMG). Data will be analyzed to compare how each intervention affects recovery, including physical performance, cognitive function, and psychological state.
The study will show which methods help master runners recover faster and more effectively, provide practical strategies to improve performance and reduce injury risk, and offer information on the separate and combined effects of tDCS and PC on recovery, which could help design age-specific recovery strategies for endurance athletes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
tDCS to Increase Aerobic Performance in Runners
NCT04005846
3D Analysis of the Effects of tDCS (Transcranial Direct Current Stimulation) on a Functional Task in High Level Athletes
NCT03901222
Searching for the Optimal tDCS Target Combined With Peripheral Electrical Stimulation in Chronic Low Back Pain
NCT04496661
Comparing Transcranial Direct Current Stimulation Montages in Stroke
NCT04340973
EEG Analytics to Determine Effectiveness of a tDCS Protocol
NCT03537885
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will be conducted as a randomized, controlled, crossover trial using a mixed experimental design. Each participant will undergo four different recovery protocols in a randomized order, with a one-week interval between sessions. Randomization will be performed using Research Randomizer, assigning participants to one of four sequences (e.g., B-A-D-C). Participants will be identified only by numerical codes to ensure blinding and maintain confidentiality. Each participant will experience all protocols, allowing within-subject comparisons and minimizing order-related bias.
The four recovery protocols are:
(A) tDCS group: transcranial direct current stimulation only (B) PC group: pneumatic compression (PC) only (C) tDCS + PC group: simultaneous application of both tDCS and PC (D) Control group: passive rest with no intervention
The tDCS and PC interventions represent the independent variables, while dependent variables include the Well-being Questionnaire (WBQ), Total Quality Recovery (TQR), heart rate variability (HRV), Stroop Test performance, vertical jump height, and maximal voluntary isometric contraction (MVIC) with electromyography (EMG) recordings.
Participants will be 35 male long-distance master runners aged 40-55 years, residing in Bursa, Turkey, with at least five years of consistent training. Participants will train five days per week for approximately 90 minutes per day and must meet aerobic fitness criteria established by the American College of Sports Medicine, including completion of an official 10-kilometer race under 50 minutes within the past six months and maintenance of a weekly running volume of 60-80 kilometers. Volunteers will be recruited from the local long-distance running community familiar to the principal investigator, Hilal Oruç Kaya.
Participants will be excluded if they have used regular medications within the last six months; consumed stimulants, caffeine, or alcohol within 24 hours prior to testing; smoke; have experienced musculoskeletal injuries within the past six months; are currently undergoing physical therapy; or have neurological conditions such as epilepsy or a history of seizures, or possess cardiac, brain, or other electronic implants. Additional exclusion criteria include open wounds or dermatological conditions on the head, circulatory disorders such as deep vein thrombosis, peripheral arterial disease, severe varicose veins, or prior exposure to tDCS or PC interventions. Participants may withdraw voluntarily, fail to attend sessions, or be removed if cardiovascular, neurological, or orthopedic complications occur during exercise or interventions, or if they experience excessive discomfort or adverse effects from the tDCS or PC procedures. Written informed consent will be obtained after participants are informed about the study's purpose, procedures, potential risks, and benefits.
Sample size was calculated using G\*Power version 3.1.9.7 for repeated-measures analysis of variance with within-between interaction, assuming an effect size of f = 0.30, an alpha level of 0.05, and a statistical power of 0.80, resulting in a required sample size of 28 participants. To account for potential dropouts, a total of 35 participants will be recruited.
Screening and Familiarization Session
Participants will undergo anthropometric measurements (body mass, body fat percentage, and height) using a Tanita BC 418 MA body composition analyzer and a Seca stadiometer. Physical fitness will be evaluated using a 12-minute Cooper Test conducted on a 400-meter outdoor track under controlled environmental conditions (temperature 20-24°C, relative humidity 50-70%, wind speed ≤10 km/h). A standardized 20-minute warm-up, including jogging, accelerations, jumps, and stretching exercises, will precede the test. Distances will be recorded using a Polar V3 global positioning system (GPS) watch.
Participants will also complete a familiarization session with the 10-kilometer running course, tDCS and PC devices, the Stroop Test, MVIC procedures, and vertical jump assessments to ensure understanding of all study procedures.
Experimental Sessions
Pre-run Measurements (T1): Participants will complete the Well-being Questionnaire (WBQ) and Total Quality Recovery (TQR) scales. Heart rate (HR) and heart rate variability (HRV) will be recorded for 10 minutes using a Polar V3 GPS watch and an H10 heart rate monitor. Cognitive performance will be assessed using the Stroop Test, vertical jump height will be measured, and MVIC of the quadriceps muscles will be recorded with electromyography (EMG).
10-Kilometer Run: Participants will complete a 10-kilometer run at 75% exercise intensity calculated using the Karvonen formula. Exercise intensity will be monitored using GPS and HR data. Perceived exertion will be assessed using the Borg 20-point Rating of Perceived Exertion scale at the 5-kilometer mark and immediately after completion of the run.
Post-run Measurements (T2): All measurements obtained at T1 will be repeated immediately after the 10-kilometer run.
Interventions
Participants will be randomly assigned to one of the four recovery protocols:
tDCS: 20 minutes of 2 mA stimulation applied to the F3 and F4 regions of the dorsolateral prefrontal cortex in a semi-reclined position using the Brain Premier device
PC: 20 minutes of sequential pneumatic compression applied to the lower limbs using the Normatec pneumatic compression system, with compression pressure adjustable between 20 and 100 mmHg, following standardized pressure and timing protocols
tDCS + PC: simultaneous application of both interventions for 20 minutes
Control: passive rest in a semi-reclined position for 20 minutes
Participants in the tDCS conditions will report sensations and perceived intensity of stimulation (e.g., itching, burning, discomfort) using a structured questionnaire.
Post-intervention Measurements (T3): All measurements obtained at T1 will be repeated immediately after the intervention.
Outcome Measures
Subjective recovery measures: Well-being Questionnaire (WBQ) and Total Quality Recovery (TQR)
Autonomic measures: heart rate variability (HRV) and GPS-derived data
Cognitive performance assessed using the Stroop Test
Vertical jump height assessed using the My Jump application
MVIC of the quadriceps muscles recorded with electromyography (EMG) following the Surface Electromyography for the Non-Invasive Assessment of Muscles (SENIAM) guidelines
Statistical Analysis
Data will be analyzed using IBM SPSS Statistics version 29. Normality will be assessed using the Shapiro-Wilk test, homogeneity of variances using Levene's test, and sphericity using Mauchly's test. A two-way repeated-measures analysis of variance (4 Time × 4 Condition) will be used to evaluate interaction effects, with Bonferroni-adjusted post hoc comparisons applied when appropriate. Effect sizes will be reported using partial eta squared (ηp²), with values of \>0.01 considered small, \>0.06 medium, and \>0.14 large. Statistical significance will be set at p \< 0.05.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
tDCS
20 minutes of transcranial direct current stimulation (tDCS) applied to the F3 and F4 regions of the brain using the Brain Premier device at 2 mA intensity.
Transcranial Direct Current Stimulation (tDCS)
20 minutes of tDCS applied to F3 and F4 (left and right dorsolateral prefrontal cortex) at 2 mA using Brain Premier device in a semi-reclined position.
Pneumatic Compression (PC)
20 minutes of sequential pneumatic compression (PC) applied to the lower limbs using the Normatec device, with compression pressure adjustable between 20 to 100 mmHg.
Normatec Pneumatic Compression
20 minutes of sequential pneumatic compression applied to lower limbs using Normatec device, following pressure/timing protocols (pressure 20-100 mmHg).
tDCS + PC
Participants will receive simultaneous application of transcranial direct current stimulation (tDCS) to the F3 and F4 regions and pneumatic compression (PC) to the lower limbs for 20 minutes, combining both interventions.
Transcranial Direct Current Stimulation (tDCS)
20 minutes of tDCS applied to F3 and F4 (left and right dorsolateral prefrontal cortex) at 2 mA using Brain Premier device in a semi-reclined position.
Normatec Pneumatic Compression
20 minutes of sequential pneumatic compression applied to lower limbs using Normatec device, following pressure/timing protocols (pressure 20-100 mmHg).
Control
20 minutes of passive rest in a semi-reclined position, no intervention applied.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcranial Direct Current Stimulation (tDCS)
20 minutes of tDCS applied to F3 and F4 (left and right dorsolateral prefrontal cortex) at 2 mA using Brain Premier device in a semi-reclined position.
Normatec Pneumatic Compression
20 minutes of sequential pneumatic compression applied to lower limbs using Normatec device, following pressure/timing protocols (pressure 20-100 mmHg).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Completion of an official 10-kilometer race in under 50 minutes within the last six months
* Regular training 5 days per week, 90 minutes per day
* Weekly running volume of 60-80 kilometers
* Aerobic fitness ≥ 80% according to American College of Sports Medicine (ACSM) guidelines
Exclusion Criteria
* Consumption of stimulants, caffeine, or alcohol within 24 hours prior to testing
* Smoking
* Musculoskeletal injuries within the last six months
* Participation in current physical therapy programs
* Epilepsy or history of seizures
* Cardiac, brain, or other electronic implants
* Open wounds or dermatological conditions on the head
* Circulatory disorders, including deep vein thrombosis, peripheral arterial disease, or severe varicose veins
* Previous exposure to transcranial direct current stimulation (tDCS) or pneumatic compression (PC) interventions
40 Years
55 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Scientific and Technological Research Council of Turkey
OTHER
Uludag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ramiz ARABACI
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bursa Uludag University, Faculty of Sport Sciences
Bursa, Nilüfer, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Goncalves DS, Moscaleski LA, da Silva GM, Morgans R, Okano AH, Moreira A. The Effect of Combined Transcranial Direct Current Stimulation and Pneumatic Compression as Part of a Comprehensive Recovery Strategy in Professional Male Top-Level Soccer Players. J Strength Cond Res. 2024 Sep 1;38(9):1658-1666. doi: 10.1519/JSC.0000000000004844. Epub 2024 Jul 23.
Shiravand F, Motamedi P, Amani-Shalamzari S, Amiri E, da Silva Machado DG. Effect of repeated sessions of transcranial direct current stimulation on subjective and objective measures of recovery and performance in soccer players following a soccer match simulation. Sci Rep. 2024 Sep 6;14(1):20809. doi: 10.1038/s41598-024-71701-y.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-17/11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.